Non-Alcoholic Fatty Liver Disease is Not Associated with Vitamin D Deficiency in Essential Hypertension

[1]  C. Catena,et al.  Low serum 25-hydroxyvitamin D levels are associated with left ventricular hypertrophy in essential hypertension. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[2]  S. Roberts,et al.  D-livering the message: the importance of vitamin D status in chronic liver disease. , 2012, Journal of hepatology.

[3]  S. Morini,et al.  Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes , 2011, BMC medicine.

[4]  C. Housset,et al.  Vitamin D and the vitamin D receptor in liver pathophysiology. , 2011, Clinics and research in hepatology and gastroenterology.

[5]  C. Rosen.  Clinical practice. Vitamin D insufficiency. , 2011, The New England journal of medicine.

[6]  D. Harnois,et al.  Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease , 2011 .

[7]  N. Parekh,et al.  Suspected Nonalcoholic Fatty Liver Disease Is Not Associated with Vitamin D Status in Adolescents after Adjustment for Obesity , 2011, Journal of obesity.

[8]  M. Kiely,et al.  Vitamin D and cardiometabolic health: a review of the evidence , 2010, Nutrition Research Reviews.

[9]  H. Tilg,et al.  Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis , 2010, Hepatology.

[10]  M. Ermani,et al.  Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[11]  T. Pieber,et al.  Vitamin D status and arterial hypertension: a systematic review , 2009, Nature Reviews Cardiology.

[12]  S. Booth,et al.  Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. , 2009, Journal of NutriLife.

[13]  L. Sechi,et al.  Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients , 2008, Journal of hypertension.

[14]  Z. Guo,et al.  1,25‐Dihydroxyvitamin D improved the free fatty‐acid‐induced insulin resistance in cultured C2C12 cells , 2008, Diabetes/metabolism research and reviews.

[15]  N. Wareham,et al.  Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance , 2008, Diabetes.

[16]  A. Kotronen,et al.  Fatty Liver: A Novel Component of the Metabolic Syndrome , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[17]  G. Targher,et al.  Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[18]  Renata Cifkova,et al.  Erratum: Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology (Journal of Hypertension (2007) 25, (1105-1187)) , 2007 .

[19]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[20]  P. Angulo.  GI Epidemiology: nonalcoholic fatty liver disease , 2007, Alimentary pharmacology & therapeutics.

[21]  M. Saad,et al.  Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .

[22]  A. Ferguson,et al.  Cows' Milk Intolerance , 1988, Nutrition Research Reviews.